Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18732 | 26979740 | J Physiol Biochem | Maternal obesity alters endoplasmic reticulum homeostasis in offspring pancreas. | 2016 | Details |
| A18733 | 26979540 | Magn Reson Imaging | Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. | 2016 | Details |
| A18734 | 26978730 | Child Obes | Sleep Duration and Media Time Have a Major Impact on Insulin Resistance and Metabolic Risk Factors in Obese Children and Adolescents. | 2016 | Details |
| A18735 | 26978356 | Int J Mol Sci | Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. | 2016 | Details |
| A18736 | 26977813 | PLoS One | Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. | 2016 | Details |
| A18737 | 26977758 | Am J Gastroenterol | The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18738 | 26977755 | Am J Gastroenterol | Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study. | 2016 | Details |
| A18739 | 26977393 | Mol Metab | Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption. | 2016 | Details |
| A18740 | 26977168 | Hepat Mon | Association Between LYPLAL1 rs12137855 Polymorphism With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease in a Chinese Han Population. | 2015 | Details |
| A18741 | 26976710 | Endocrinol Nutr | Effect of incretin therapies compared to pioglitazone and gliclazide in non-alcoholic fatty liver disease in diabetic patients not controlled on metformin alone: An observational, pilot study. | 2016 | Details |
| A18742 | 26976285 | BMC Gastroenterol | Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention. | 2016 | Details |
| A18743 | 26976243 | Am J Pathol | Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance. | 2016 | Details |
| A18744 | 26975539 | Metabolism | Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case-control study in China. | 2015 | Details |
| A18745 | 26973398 | World J Gastroenterol | Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. | 2016 | Details |
| A18746 | 26973390 | World J Gastroenterol | Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. | 2016 | Details |
| A18747 | 26972505 | J Ethnopharmacol | Schisandra chinensis extract ameliorates nonalcoholic fatty liver via inhibition of endoplasmic reticulum stress. | 2016 | Details |
| A18748 | 26972222 | Metabolism | Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet? | 2016 | Details |
| A18749 | 26972165 | Best Pract Res Clin Obstet Gynaecol | Metabolic syndrome, diet and exercise. | 2016 | Details |
| A18751 | 26971826 | Gastroenterology | Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management. | 2016 | Details |
| A18752 | 26971824 | Gastroenterology | Perspectives on Treatment for Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18753 | 26971813 | Gene | Identification and differential expression of microRNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease. | 2016 | Details |
| A18754 | 26970319 | Pediatr Diabetes | A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. | 2016 | Details |
| A18755 | 26970305 | Biochem Biophys Res Commun | Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress. | 2016 | Details |
| A18756 | 26969270 | BMC Res Notes | Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists. | 2016 | Details |
| A18757 | 26968296 | J Pak Med Assoc | Endocrine and metabolic effects of Glucagon like peptide 1 receptor agonists (GLP1RA). | 2016 | Details |
| A18758 | 26968211 | Am J Physiol Gastrointest Liver Physiol | Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. | 2016 | Details |
| A18759 | 26965771 | Asia Pac J Clin Nutr | Insulin resistance, body composition, and fat distribution in obese children with nonalcoholic fatty liver disease. | 2016 | Details |
| A18760 | 26965314 | Lipids Health Dis | Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review. | 2016 | Details |
| A18761 | 26962056 | Toxicol Sci | Vinyl Chloride Metabolites Potentiate Inflammatory Liver Injury Caused by LPS in Mice. | 2016 | Details |
| A18762 | 26962021 | Biochim Biophys Acta | Nuclear receptors and nonalcoholic fatty liver disease. | 2016 | Details |
| A18763 | 26961580 | Metabolism | Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. | 2016 | Details |
| A18764 | 26960729 | Abdom Radiol (NY) | Comparison of Doppler ultrasound and transient elastography in the diagnosis of significant fibrosis in patients with nonalcoholic steatohepatitis. | 2016 | Details |
| A18766 | 26959535 | J Pediatr Endocrinol Metab | Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children. | 2016 | Details |
| A18767 | 26959059 | Nutrients | The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. | 2016 | Details |
| A18768 | 26957957 | Afr Health Sci | Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis. | 2015 | Details |
| A18769 | 26955623 | Adv Biomed Res | Effect of garlic powder consumption on body composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. | 2016 | Details |
| A18770 | 26955458 | Int J Prev Med | The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18771 | 26955242 | J Korean Med Sci | The Risk of Abdominal Obesity according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men. | 2016 | Details |
| A18772 | 26954660 | South Med J | Prevalence of Pancreatic Steatosis at a Pediatric Tertiary Care Center. | 2016 | Details |
| A18773 | 26952573 | Exp Gerontol | β2-Adrenergic receptor ablation modulates hepatic lipid accumulation and glucose tolerance in aging mice. | 2016 | Details |
| A18774 | 26950158 | J Clin Med | Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. | 2016 | Details |
| A18776 | 26949499 | Iran J Basic Med Sci | Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case-control study. | 2015 | Details |
| A18777 | 26948887 | Gastroenterology | Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? | 2016 | Details |
| A18779 | 26947067 | Cell Rep | The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. | 2016 | Details |
| A18780 | 26946784 | Nihon Arukoru Yakubutsu Igakkai Zasshi | [Diagnostic accuracy for alcoholic liver disease with controlled Attenuation Parameter (CAP) measured by transient elastography for the non-invasive assessment of liver steatosis]. | 2015 | Details |
| A18781 | 26946071 | J Gastroenterol Hepatol | Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients. | 2016 | Details |
| A18782 | 26945512 | Chem Biol Interact | Metformin administration induces hepatotoxic effects in paraoxonase-1-deficient mice. | 2016 | Details |
| A18783 | 26945479 | Liver Int | Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects. | 2016 | Details |
| A18784 | 26944023 | Contemp Clin Trials | Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design. | 2016 | Details |
| A18785 | 26942734 | Dig Dis Sci | Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18786 | 26942201 | Biomed Res Int | Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice. | 2016 | Details |
| A18787 | 26941577 | Int J Med Sci | Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18788 | 26941037 | J Endocrinol | Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. | 2016 | Details |
| A18789 | 26938481 | Hepatol Res | Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors. | 2016 | Details |
| A18790 | 26937147 | World J Gastroenterol | Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease. | 2016 | Details |
| A18791 | 26937141 | World J Gastroenterol | Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation. | 2016 | Details |
| A18792 | 26937139 | World J Gastroenterol | Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice. | 2016 | Details |
| A18793 | 26937137 | World J Gastroenterol | Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. | 2016 | Details |
| A18794 | 26937136 | World J Gastroenterol | Glycosyltransferases and non-alcoholic fatty liver disease. | 2016 | Details |
| A18795 | 26936230 | Sci Rep | Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity. | 2016 | Details |
| A18796 | 26935501 | Adv Clin Exp Med | 13C-Methacetin Breath Testing in Patients with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18797 | 26935030 | Sci Rep | Heat Shock Protein 27 is down-regulated in Ballooned Hepatocytes of Patients with Nonalcoholic Steatohepatitis (NASH). | 2016 | Details |
| A18799 | 26934227 | Nature | NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. | 2016 | Details |
| A18800 | 26933479 | Middle East J Dig Dis | Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18801 | 26932908 | J Neurogastroenterol Motil | Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18802 | 26932748 | Sci Rep | Involvement of splenic iron accumulation in the development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese Diabetes mice. | 2016 | Details |
| A18803 | 26932594 | Hepatol Res | Hypertension and non-alcoholic fatty liver disease proven by transient elastography. | 2016 | Details |
| A18804 | 26932533 | Int J Food Sci Nutr | Medium-chain fatty acid reduces lipid accumulation by regulating expression of lipid-sensing genes in human liver cells with steatosis. | 2016 | Details |
| A18805 | 26930651 | PLoS One | Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies. | 2016 | Details |
| A18806 | 26929777 | Therap Adv Gastroenterol | Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial. | 2016 | Details |
| A18807 | 26928243 | Gastroenterology | Pathogenesis of Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18808 | 26927097 | Int J Mol Sci | Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease. | 2016 | Details |
| A18810 | 26926384 | Hepatology | Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice. | 2016 | Details |
| A18811 | 26925881 | Am J Gastroenterol | Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18812 | 26924554 | BMC Gastroenterol | Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology. | 2016 | Details |
| A18813 | 26924542 | J Autoimmun | Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model. | 2016 | Details |
| A18816 | 26923972 | Clin Calcium | [Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition]. | 2016 | Details |
| A18817 | 26923892 | Arch Iran Med | Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. | 2016 | Details |
| A18819 | 29115108 | Fukuoka Igaku Zasshi | A Probable Case of Burn-out NASH Caused by Panhypopituitarism Secondary to Craniopharyngioma. | 2016 | Details |
| A18820 | 26921863 | J Affect Disord | Insulin receptor sensitizer, dicholine succinate, prevents both Toll-like receptor 4 (TLR4) upregulation and affective changes induced by a high-cholesterol diet in mice. | 2016 | Details |
| A18821 | 26921205 | Adv Ther | The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. | 2016 | Details |
| A18822 | 26921078 | Dig Dis Sci | Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD. | 2016 | Details |
| A18823 | 26919834 | Chin J Integr Med | Effect of Total Flavone of Haw Leaves on Nuclear Factor Erythroid-2 Related Factor and Other Related Factors in Nonalcoholic Steatohepatitis Rats. | 2016 | Details |
| A18824 | 26919573 | Hepatology | A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. | 2016 | Details |
| A18825 | 26916997 | Br J Nutr | High serum carotenoids are associated with lower risk for developing elevated serum alanine aminotransferase among Japanese subjects: the Mikkabi cohort study. | 2016 | Details |
| A18826 | 26916498 | Australas J Dermatol | Psoriasis and the liver: problems, causes and course. | 2016 | Details |
| A18827 | 26916089 | Histol Histopathol | Relationships between variable time, percentage of food restriction and liver histology: which alternative is the best for non-alcoholic fatty liver disease (NAFLD) prevention? | 2016 | Details |
| A18828 | 26915720 | Gen Physiol Biophys | Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet. | 2016 | Details |
| A18829 | 26914659 | Clin Drug Investig | Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors. | 2016 | Details |
| A18830 | 26914024 | PLoS One | White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice. | 2016 | Details |
| A18832 | 26912655 | J Biol Chem | Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells. | 2016 | Details |
| A18833 | 26912150 | Diabetes Metab J | Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis. | 2016 | Details |
| A18834 | 26911834 | Sci Rep | Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis. | 2016 | Details |
| A18835 | 26911638 | Neurology | Nonalcoholic fatty liver disease is associated with cognitive function in adults. | 2016 | Details |
| A18836 | 26911214 | Indian J Public Health | Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. | 2019 | Details |
| A18837 | 26909902 | Genet Mol Res | Association between adiponectin gene T45G polymorphism and nonalcoholic fatty liver disease risk: a meta-analysis. | 2016 | Details |
| A18838 | 26909311 | Mol Metab | Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity. | 2015 | Details |
| A18839 | 26909307 | Mol Metab | High intensity interval training improves liver and adipose tissue insulin sensitivity. | 2015 | Details |
| A18840 | 26909306 | Mol Metab | Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism. | 2015 | Details |
| A18841 | 26908279 | Curr Gastroenterol Rep | Targeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise Literature. | 2016 | Details |